Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Immunocore Holdings plc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +2 vs. Q2 2021
- Shares held
- 16.7M
- +2.27M (+15.8%) vs. Q2 2021
- Total value
- $617.4M
- +$56.2M (+10.0%) vs. Q2 2021
- New holders
- 7
- 15 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Hong Kong Ltd | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 25 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 123 | $4.00K | 0.00% | −6−4.7% | Reduced |
| State of Wyoming | 143 | $5.00K | 0.00% | −69−32.5% | Reduced |
| Cubist Systematic Strategies, LLC | 500 | $19.0K | 0.00% | +500 | New |
| Bank of America Corp | 2,253 | $84.0K | 0.00% | +2,108+1,453.8% | Added |
| Morgan Stanley | 2,321 | $86.0K | 0.00% | +2,301+11,505.0% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $143.0K | 0.00% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 4,235 | $157.0K | 0.02% | +4,235 | New |
| Geneos Wealth Management Inc. | 4,250 | $163.0K | 0.01% | +4,250 | New |
| Virtus ETF Advisers LLC | 5,359 | $199.0K | 0.09% | −275−4.9% | Reduced |
| Geode Capital Management, LLC | 5,997 | $222.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 6,200 | $230.0K | 0.00% | +6,200 | New |
| Boothbay Fund Management, LLC | 6,826 | $253.0K | 0.01% | +770+12.7% | Added |
| Victory Capital Management Inc | 9,528 | $353.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14,001 | $519.0K | 0.00% | +1,987+16.5% | Added |
| ETF Managers Group, LLC | 16,292 | $603.0K | 0.01% | +3,130+23.8% | Added |
| Citadel Advisors LLC | 22,528 | $835.0K | 0.00% | −28,782−56.1% | Reduced |
| Marshall Wace North America L.P. | 25,144 | $932.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 25,277 | $933.0K | 0.00% | +6,186+32.4% | Added |
| TD Asset Management Inc | 27,506 | $1.02M | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 50,000 | $1.85M | 0.14% | +50,000 | New |
| Omega Fund Management, LLC | 51,535 | $1.91M | 0.21% | 00.0% | Unchanged |
| Alps Advisors Inc | 53,663 | $1.99M | 0.02% | −3,610−6.3% | Reduced |
| Samsara BioCapital, LLC | 64,000 | $2.37M | 0.39% | 00.0% | Unchanged |
| Pier Capital, LLC | 78,514 | $2.91M | 0.30% | +78,514 | New |
| Rhenman & Partners Asset Management AB | 90,000 | $3.34M | 0.23% | 00.0% | Unchanged |
| Millennium Management LLC | 93,812 | $3.48M | 0.00% | −9,309−9.0% | Reduced |
| Point72 Asset Management, L.P. | 149,000 | $5.52M | 0.03% | +76,100+104.4% | Added |
| Principal Financial Group Inc | 184,925 | $6.86M | 0.00% | +7,820+4.4% | Added |
| First Manhattan Co | 197,999 | $7.34M | 0.03% | +197,999 | New |
| Artal Group S.A. | 200,000 | $7.41M | 0.18% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 277,754 | $10.3M | 0.13% | 00.0% | Unchanged |
| Massachusetts Financial Services Co | 335,512 | $12.4M | 0.00% | +238,286+245.1% | Added |
| Thrivent Financial for Lutherans | 350,214 | $13.0M | 0.03% | +1,400+0.4% | Added |
| Price T Rowe Associates Inc | 362,026 | $13.4M | 0.00% | −5,278−1.4% | Reduced |
| Perceptive Advisors LLC | 400,000 | $14.8M | 0.22% | 00.0% | Unchanged |
| Bill & Melinda Gates Foundation | 576,923 | $21.4M | 6.26% | 00.0% | Unchanged |
| Bain Capital Public Equity Management II, LLC | 638,205 | $23.7M | 0.96% | +163,651+34.5% | Added |
| BlackRock Inc. | 827,604 | $30.7M | 0.00% | −252,322−23.4% | Reduced |
| General Atlantic LLC | 950,000 | $35.2M | 0.21% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,052,075 | $39.0M | 0.01% | +760,563+260.9% | Added |
| Avidity Partners Management LP | 1,095,600 | $40.6M | 1.04% | +494,600+82.3% | Added |
| RTW Investments, LP | 1,245,532 | $46.2M | 0.70% | 00.0% | Unchanged |
| FMR LLC | 2,180,986 | $80.8M | 0.01% | +949,142+77.1% | Added |
| Rock Springs Capital Management LP | 2,445,155 | $90.6M | 1.91% | +50,370+2.1% | Added |
| Baker Bros. Advisors LP | 2,520,730 | $93.4M | 0.41% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −360,966−100.0% | Sold out |
| Tybourne Capital Management (HK) Ltd | 0 | $0 | 0.00% | −138,192−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −16,685−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −12,896−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |